Cargando…
A European perspective of phylogenomics, sublineages, geographical distribution, epidemiology, and mutational landscape of mpox virus: Emergence pattern may help to fight the next public health emergency in Europe
BACKGROUND: The 2022 outbreak of the mpox virus (previously monkeypox virus, MPXV) in non-epidemic regions has created a global issue. The emergence of MPXV was first reported in Europe, which was described as the MPXV epicenter, however, no reports are available to illustrate its outbreak patterns...
Autores principales: | Chakraborty, Chiranjib, Bhattacharya, Manojit, Saikumar, G., Alshammari, Abdulrahman, Alharbi, Metab, Lee, Sang-Soo, Dhama, Kuldeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147450/ https://www.ncbi.nlm.nih.gov/pubmed/37172461 http://dx.doi.org/10.1016/j.jiph.2023.04.017 |
Ejemplares similares
-
A novel mutation-proof, next-generation vaccine to fight against upcoming SARS-CoV-2 variants and subvariants, designed through AI enabled approaches and tools, along with the machine learning based immune simulation: A vaccine breakthrough
por: Bhattacharya, Manojit, et al.
Publicado: (2023) -
Revealing the structural and molecular interaction landscape of the favipiravir-RTP and SARS-CoV-2 RdRp complex through integrative bioinformatics: Insights for developing potent drugs targeting SARS-CoV-2 and other viruses
por: Chakraborty, Chiranjib, et al.
Publicado: (2023) -
Evolution, epidemiology, geographical distribution, and mutational landscape of newly emerging monkeypox virus
por: Chakraborty, Chiranjib, et al.
Publicado: (2022) -
SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic
por: Chakraborty, Chiranjib, et al.
Publicado: (2023) -
Immediate need for next-generation and mutation-proof vaccine to protect against current emerging Omicron sublineages and future SARS-CoV-2 variants: An urgent call for researchers and vaccine companies – Correspondence
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)